Infanrix-Ipv+hib (Haemophilus Type B Conjugate Vaccine (Tetanus Toxoid Conjugate), Poliovirus (Inactivated) Type 3 (Sa)

The vaccine contains purified antigens from each target pathogen. When injected, these antigens are processed by the immune system, prompting B‑cells and T‑cells to produce specific antibodies and memory cells that provide long‑lasting protection against diphtheria, tetanus, pertussis, polio and Hib.

The dosing schedule is determined by the prescribing healthcare professional according to national immunisation guidelines. Typically, the vaccine is given as a series of intramuscular injections at specific ages during infancy and early childhood.

The vaccine is not routinely administered to pregnant women, and safety data in pregnancy are limited. Breastfeeding mothers may receive the vaccine if the clinical benefit outweighs any potential risk, but this decision should be made in consultation with a qualified healthcare provider.

Enquiries are submitted via the product page on gnhindia.com. Provide the required quantity and institutional credentials. GNH India will verify trade or institutional eligibility, then respond with pricing, availability, cold‑chain shipping details and any necessary import documentation.

Infanrix-Ipv+hib combines diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Hib antigens in a single injection, reducing the number of shots compared with separate vaccines. Alternatives such as Pentacel lack the polio component, while some other Hib‑containing products may not include pertussis, making Infanrix-Ipv+hib a more comprehensive option for the recommended pediatric schedule.

The vaccine must be stored refrigerated at 2 °C to 8 °C. It should be kept in its original packaging, protected from light, and must never be frozen or shaken. Maintain the cold chain during transport and handling to preserve potency.

Infanrix-Ipv+hib is given by intramuscular injection. In infants, the preferred site is the anterolateral thigh; in older children, the deltoid muscle of the upper arm may be used. The injection is performed by a qualified healthcare professional following aseptic technique.

Serious adverse events are rare but can include severe allergic reactions (anaphylaxis), high‑grade fever leading to seizures, hypotonic‑hyporesponsive episodes, and, in extremely uncommon cases, neurologic complications such as encephalopathy. Immediate medical attention is required if any of these signs appear.

Individuals with a known severe allergy to any component of the vaccine or who have experienced a previous severe reaction to a dose of this vaccine should not be vaccinated. Children with acute moderate or severe illness should defer vaccination until recovery.